Department of Health and Social Care
Printable version

£5 million given to AMR research partnerships between UK and Argentina

The government has provided £5 million of UK aid as part of a programme to manage antimicrobial resistance (AMR) in agriculture and its impact on the environment.

The funding will go to 5 research partnerships between the UK and Argentina.

It has been awarded through the Global AMR Innovation Fund (GAMRIF) and will be matched in staff and lab resources by the National Scientific and Technical Research Council (CONICET) in Argentina.

British and Argentinian researchers are launching the ‘Tools to tackle AMR in the environment’ programme in Buenos Aires this week.

The partnerships receiving the award are:

The research will benefit low- and middle-income countries, which are disproportionately impacted by AMR.

The programme will be delivered on behalf of GAMRIF by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Natural Environment Research Council (NERC) in the UK and by CONICET in Argentina.

The use of antimicrobial drugs in livestock production is a primary contributor to the development and spread of AMR. Drug-resistant microbes can be transmitted from animals to humans via direct contact or through the food chain and the environment, which poses a potential significant threat to human health.

Mark Kent, the UK Ambassador to the Argentine Republic, yesterday said:

Today’s announcement is further evidence that the UK is committed to working with Argentina to help tackle global issues. Antimicrobial resistance is a threat which is killing hundreds of thousands of people across the world each year.

The research programme represents the best of British and Argentinian technical abilities, and will have an international impact. Tackling antimicrobial resistance is a global priority, and investigating AMR in agriculture and the environment is crucial.

This partnership is exciting, not only because it is good for UK and Argentinian science, but because the benefits could be shared with developing and emerging economies around the world.

Dr Jorge Tezon, Director of Scientific Development at CONICET, yesterday said:

High-quality research is needed to increase our ability to effectively treat bacterial infections in humans and animals. That’s why CONICET has decided to partner with DHSC, BBSRC and NERC and promote joint research projects.

At the national level, Argentina promotes interdisciplinary work with different actors focused on the concept of ‘one health’. This research programme is particularly important as it involves interaction between national stakeholders on AMR.

We also expect that this could benefit other countries and regions around the world which are disproportionately affected by AMR and help them improve food security and the associated economics.


Channel website:

Original article link:

Share this article

Latest News from
Department of Health and Social Care